Investing Profile

Larry Lasky

InvestorVC
Partner at The Column Group
thecolumngroup.com/team/Sausalito
Photo of Larry Lasky, Partner at The Column Group
Your Intro Paths to Larry Lasky

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Larry Lasky on

cb
Current Investing Position
The Column Group Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
13
Current Fund Size
$600M

Larry Lasky is on these Sector & Stage Rankings

Larry Lasky's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Accent Therapeutics
Series CJan 2024$75M
Series BApr 2020$63M
Series AMay 2018$40M
$180M
Co-investors: Jason Rhodes (Atlas Venture), Naveen Krishnan (Leaps by Bayer)
Eikon Therapeutics
Series BJan 2022$520M
Series AMay 2021$150M
$670M
Co-investors: Adam Goulburn (Lux Capital Management), Leon Chen (The Column Group), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
Revolution Medicines
Series CJul 2019$100M
Series BApr 2018$56M
Series ADec 2016$25M
$180M
Co-investors: Thilo Schroeder (Nextech Invest)
Cleave Therapeutics
Series ANov 2011$42M
$100M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Robert Garland (New Enterprise Associates (NEA)), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Marc Singer (Osage University Partners), Alfred Scheidegger (Nextech Invest)
Calithera Biosciences
Series UnknownNov 2011$4M
Series AJul 2010$40M
$81M
Co-investors: Ralph (Chris) Christoffersen (Morgenthaler Ventures), Jean George (Advanced Technology Ventures), Christoph Westphal (Longwood Fund)
OncoMed Pharmaceuticals
Series BNov 2008$150M
Series ASep 2005$14M
$170M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))